biote Corp.
$2.24
▲
11.19%
2026-04-21 05:48:01
www.biote.com
NGM: BTMD
Explore biote Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$87.8 M
Current Price
$2.24
52W High / Low
$4.75 / $1.27
Stock P/E
3.25
Book Value
$-1.91
Dividend Yield
—
ROCE
56.77%
ROE
-32.89%
Face Value
—
EPS
$0.74
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
223
Beta
1.29
Debt / Equity
-1.88
Current Ratio
1.22
Quick Ratio
0.79
Forward P/E
2.79
Price / Sales
0.31
Enterprise Value
$142.78 M
EV / EBITDA
3.8
EV / Revenue
0.74
Rating
None
Target Price
$3.17
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
| 2. | The Pennant Group, Inc. | $29.64 | 35.03 | $1.04 B | — | 6.2% | 9.84% | $35 / $21.73 | $9.54 |
| 3. | PACS Group, Inc. | $36 | 28.88 | $5.53 B | — | 6.76% | 22.96% | $43.08 / $7.5 | $6.04 |
| 4. | The Oncology Institute, Inc. | $3.52 | — | $349.89 M | — | -38.51% | 999.19% | $4.88 / $1.8 | $-0.16 |
| 5. | National HealthCare Corporation | $166.58 | 21.66 | $2.6 B | 1.54% | 10.08% | 11.92% | $177.47 / $89.4 | $68.79 |
| 6. | Acadia Healthcare Company, Inc. | $27.84 | — | $2.56 B | — | 7.76% | -40.96% | $28.48 / $11.43 | $21.55 |
| 7. | U.S. Physical Therapy, Inc. | $75.72 | 28.66 | $431.66 M | 2.43% | 7.55% | 7.59% | $93.5 / $64.99 | $31.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 46.41 M | 47.96 M | 48.86 M | 48.99 M | 49.83 M |
| Operating Profit | 6.83 M | 8.27 M | 10.77 M | 9.69 M | 2.77 M |
| Net Profit | 1.95 M | 8.19 M | 3.19 M | 13.72 M | 3.7 M |
| EPS in Rs | 0.06 | 0.26 | 0.1 | 0.43 | 0.12 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 192.22 M | 197.19 M | 185.36 M | 164.96 M |
| Operating Profit | 35.55 M | 31.61 M | 28.66 M | -60.72 M |
| Net Profit | 27.05 M | 3.16 M | 3.32 M | -0.97 M |
| EPS in Rs | 0.84 | 0.1 | 0.1 | -0.03 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 107.61 M | 122.37 M | 155.29 M | 111.64 M |
| Total Liabilities | 158.01 M | 224.57 M | 191.84 M | 169.92 M |
| Equity | -58.54 M | -105.93 M | -29.4 M | -44.46 M |
| Current Assets | 54.67 M | 68.13 M | 122.34 M | 101.18 M |
| Current Liabilities | 44.99 M | 51.51 M | 22.21 M | 18.77 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 35.19 M | 45.24 M | 26.88 M | -9.16 M |
| Investing CF | -6.86 M | -18.8 M | -2.71 M | -1.84 M |
| Financing CF | -43.55 M | -76.08 M | -14.38 M | 63.46 M |
| Free CF | 28.33 M | 38.29 M | 24.17 M | -10.99 M |
| Capex | -6.86 M | -6.96 M | -2.71 M | -1.84 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 6.38% | 12.37% | — | — |
| Earnings Growth % | -4.79% | 442.21% | — | — |
| Profit Margin % | 1.6% | 1.79% | -0.59% | — |
| Operating Margin % | 16.03% | 15.46% | -36.81% | — |
| Gross Margin % | 70.52% | 68.78% | 66.92% | — |
| EBITDA Margin % | 7.91% | 4.98% | 4.82% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.